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Introduction
------------

Septic shock is characterized by increased splanchnic blood flow due to enhanced metabolic activity. Endogenous prostacyclin may be crucial to maintain liver function and gastric mucosal integrity \[[@B1]\]. Therefore we studied the effect of intravenous. iloprost on hepatosplanchnic metabolic activity and energy balance in patients with septic shock.

Patients/methods
----------------

Twelve patients with septic shock (cardiac index, CI ≥ 3 l/min×m^2^, all requiring noradrenaline≥ 0.03 μg/kg×min^-1^ to maintain mean arterial pressure (MAP ≥ 70 mmHg) were studied. In addition to routine systemic hemodynamics and gas exchange we inserted a Swan Ganz catheter into a hepatic vein (hv) to measure splanchnic blood flow using primed continuous infusion of indocyanine-green. Moreover, we assessed splanchnic lactate uptake (Fick principle), endogenous glucose production rate (stable isotope approach), as well as hepatic venous lactate/pyruvate and acetoacetate/β-OH-butyrate ratios. Measurements obtained after 90\' of hemodynamic steady-state were recorded before, after and during iloprost infusion titrated to obtain a 20% increase in CI (0.9--3 ng/kg×min^-1^).

Results/statistics
------------------

See Table. Friedmann test/Student-Newman-Keuls: \**P*\<0.05 vs baseline.

Conclusion
----------

While maintaining hepato-splanchnic lactate clearance, iloprost reduced the endogenous glucose production rate, hence the hepatic O~2~ requirements. The unchanged regional O~2~ uptake therefore suggests shifting of O~2~ consumption to other energy demanding processes.

  (median/percentile)                Baseline         Iloprost              Baseline
  ---------------------------------- ---------------- --------------------- ----------------
  Sys. DO~2~ ml/min/m^2^             565/642-473      634/699-513           524/651-472
  Sys. VO~2~ ml/min/m^2^             139/142-131      147/164-136**^\*^**   143/154-133
  Spl. DO~2~ ml/min/m ^2^            122/166-103      134/203-117**^\*^**   130/158-98
  Spl. VO~2~ ml/min/m ^2^            58/67-49         59/71-57              56/65-52
  Spl. Lactate balance μmol/kg/min   12/13-4          13/14-2               11/13-5
  Glucose production μmol/kg/min     16**/**19-14     11/15-9**^\*^**       11/11-8
  Hv. Lactate/pyruvate               18/21-16         16/34-12              13/22-12
  Hv. Acetoacetate/β-OH-butyrate     0.21/0.59-0.13   0.22/0.45-0.08        0.22/0.34-0.05
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